120 related articles for article (PubMed ID: 11394532)
21. Binding of EGF peptide and EGF receptor antibodies and its fragments in different tumor models.
Senekowitsch-Schmidtke R
Hybridoma; 1999 Feb; 18(1):29-35. PubMed ID: 10211785
[TBL] [Abstract][Full Text] [Related]
22. Tumor targeting using anti-epidermal growth factor receptor (ior egf/r3) immunoconjugate with a tetraaza macrocyclic agent (DO3A-EA).
Mishra G; Panwar P; Mishra AK
Mol Imaging; 2012; 11(5):408-16. PubMed ID: 22954185
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.
Mendelsohn J
J Natl Cancer Inst Monogr; 1992; (13):125-31. PubMed ID: 1389685
[TBL] [Abstract][Full Text] [Related]
24. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
Yang XD; Jia XC; Corvalan JR; Wang P; Davis CG; Jakobovits A
Cancer Res; 1999 Mar; 59(6):1236-43. PubMed ID: 10096554
[TBL] [Abstract][Full Text] [Related]
25. Biodistribution of 99mTc-labeled anti-human epidermal growth factor receptor (EGF-R) humanized monoclonal antibody h-R3 in a xenograft model of human lung adenocarcinoma.
Morales-Morales A; Ducongé J; Caballero-Torres I; Núñez-Gandolff G; Fernández E; Iznaga-Escobar N
Nucl Med Biol; 1999 Apr; 26(3):275-9. PubMed ID: 10363798
[TBL] [Abstract][Full Text] [Related]
26. Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.
Kalofonos HP; Pawlikowska TR; Hemingway A; Courtenay-Luck N; Dhokia B; Snook D; Sivolapenko GB; Hooker GR; McKenzie CG; Lavender PJ
J Nucl Med; 1989 Oct; 30(10):1636-45. PubMed ID: 2795204
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.
Vanhoefer U; Tewes M; Rojo F; Dirsch O; Schleucher N; Rosen O; Tillner J; Kovar A; Braun AH; Trarbach T; Seeber S; Harstrick A; Baselga J
J Clin Oncol; 2004 Jan; 22(1):175-84. PubMed ID: 14701780
[TBL] [Abstract][Full Text] [Related]
28. Freeze-dried formulation for direct 99mTc-labeling ior-egf/r3 MAb: additives, biodistribution, and stability.
Morales AA; Núñez-Gandolff G; Pérez NP; Véliz BC; Caballero-Torres I; Ducongé J; Fernández E; Crespo FZ; Veloso A; Iznaga-Escobar N
Nucl Med Biol; 1999 Aug; 26(6):717-23. PubMed ID: 10587113
[TBL] [Abstract][Full Text] [Related]
29. Phase I/II clinical trial of the humanized anti-EGF-r monoclonal antibody h-R3 labelled with 99mTc in patients with tumour of epithelial origin.
Torres LA; Perera A; Batista JF; Hernández A; Crombet T; Ramos M; Neninger E; Pérez M; Sánchez EL; Romero S; Aguilar V; Coca MA; Iznaga-Escobar N
Nucl Med Commun; 2005 Dec; 26(12):1049-57. PubMed ID: 16264350
[TBL] [Abstract][Full Text] [Related]
30. The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.
Mendelsohn J
Semin Cancer Biol; 1990 Oct; 1(5):339-44. PubMed ID: 2103507
[TBL] [Abstract][Full Text] [Related]
31. Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer.
Solbach C; Roller M; Ahr A; Loibl S; Nicoletti M; Stegmueller M; Kreysch HG; Knecht R; Kaufmann M
Int J Cancer; 2002 Oct; 101(4):390-4. PubMed ID: 12209965
[TBL] [Abstract][Full Text] [Related]
32. Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study.
Ramalingam S; Forster J; Naret C; Evans T; Sulecki M; Lu H; Teegarden P; Weber MR; Belani CP
J Thorac Oncol; 2008 Mar; 3(3):258-64. PubMed ID: 18317068
[TBL] [Abstract][Full Text] [Related]
33. Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor.
Vollmar AM; Banker DE; Mendelsohn J; Herschman HR
J Cell Physiol; 1987 Jun; 131(3):418-25. PubMed ID: 3496342
[TBL] [Abstract][Full Text] [Related]
34. Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody.
Foon KA; Yang XD; Weiner LM; Belldegrun AS; Figlin RA; Crawford J; Rowinsky EK; Dutcher JP; Vogelzang NJ; Gollub J; Thompson JA; Schwartz G; Bukowski RM; Roskos LK; Schwab GM
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):984-90. PubMed ID: 14967460
[TBL] [Abstract][Full Text] [Related]
35. Iodine125 labeled anti-epidermal growth factor receptor-425 in the treatment of malignant astrocytomas. A pilot study.
Brady LW; Markoe AM; Woo DV; Rackover MA; Koprowski H; Steplewski Z; Peyster RG
J Neurosurg Sci; 1990; 34(3-4):243-9. PubMed ID: 1965903
[TBL] [Abstract][Full Text] [Related]
36. Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer.
Rowinsky EK; Schwartz GH; Gollob JA; Thompson JA; Vogelzang NJ; Figlin R; Bukowski R; Haas N; Lockbaum P; Li YP; Arends R; Foon KA; Schwab G; Dutcher J
J Clin Oncol; 2004 Aug; 22(15):3003-15. PubMed ID: 15210739
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical evaluation of H-R3 a novel humanized monoclonal antibody that neutralizes the EGF-receptor.
Cedeño-Arias M; Rengifo CE; Batista YR; Calzado ER; Rodríguez T
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):213-9. PubMed ID: 17525637
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of high-grade astrocytomas.
Snelling L; Miyamoto CT; Bender H; Brady LW; Steplewski Z; Class R; Emrich J; Rackover MA
Hybridoma; 1995 Apr; 14(2):111-4. PubMed ID: 7590764
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
